Johnson & Johnson’s US$25.4 B Acquisition of Guidant

By Business Review Editor

Pharma Deals Review: Vol 2005 Issue 56 (Table of Contents)

Published: 5 Feb-2005

DOI: 10.3833/pdr.v2005.i56.728     ISSN: 1756-7874

Section: Mergers & Acquisitions



The healthcare giant Johnson & Johnson (J&J) is to acquire Guidant, a major player in the growing market for pacemakers and implantable defibrillators for US$25...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details